During AD pathogenesis, Aβ is produced through the increased expression of transmembrane β-secretase β-site amyloid precursor protein (APP) cleaving enzyme1 (BACE, β-secretase) and γ-secretase, which affect APP biogenesis. This evidence concerns the gene APP and Alzheimer disease.